All In MedTech

Device Trial Radar · NCT01225952

Three Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

A Three Arm Prospective Clinical Evaluation of Three FDA-approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction

Last checked: Nov 19, 2026Latest source record: Jan 18, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

93

Actual

Start

Jul 2010

Primary completion

Jun 2011

Study completion Jul 2011

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Oct 21, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to compare the contrast sensitivity, high and low contrast visual acuity (VA), glare meter outcomes, and subject satisfaction with three different FDA-approved intraocular lenses (IOLs) designed to improve distance, intermediate, and near vision following lens extraction in adults at least 40 years of age.

Conditions

  • Cataract

Interventions

  • Crystalens AODevice

    Bausch \& Lomb model silicone multi-piece accommodating IOL.

  • ReSTOR 3.0Device

    An aspheric multifocal IOL (Alcon Laboratories) combines the functions of an apodized diffractive region and a refractive region.

  • AMO Tecnis MultifocalDevice

    The Tecnis Multifocal foldable hydrophobic acrylic IOL, Model ZMA00 (Abbott Medical Optics), is an ultraviolet light-absorbing posterior chamber IOL.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Monocular Mesopic Contrast Sensitivity Without Glare (1.5, 3 Cycles/Degree)Time frame: Postoperative visit 3 (day 30-60)
  2. Monocular Mesopic Contrast Sensitivity Without Glare(6 Cycles/Degree)Time frame: Postoperative visit 3 (day 30-60)
  3. Monocular Mesopic Contrast Sensitivity Without Glare(12 Cycles/Degree)Time frame: Postoperative visit 3 (day 30-60)

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asian Eye Institute

    Makati City, Philippines

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.